Compounds Found That Halt Hepatitis C Replication
The Editors at Hepatitis Central
January 27, 2010
Print this page
Slowing down efforts to prevent or cure Hepatitis C, this virus has an uncanny ability to mutate and become resistant to new drugs. By identifying compounds that interfere with Hepatitis C’s replication process, scientists at Stanford University have uncovered a potentially new approach for suppressing Hepatitis C that does not appear to be vulnerable to drug resistance.
Potential New Class of Drugs to Combat Hepatitis C Identified
ScienceDaily (Jan. 25, 2010) — Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus’s propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.
Continue reading this entire article:
HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.